February 26, 2004

Testimony on Isotretinoin (Accutane)

The acne drug isotretinoin (Accutane), which causes birth defects and life-threatening adverse events, should not be marketed and should prescribed only under very limited and controlled conditions. 

1. Testimony before FDA Advisory Committee
2. Letter from Dr. Curt Furberg to FDA Advisory Committee